More
An article from Reuters (published on 25 October 2016) on the subject of access to documents concerning the IARC Monographs Programme severely distorts the motives of the International Agency for Research on Cancer (IARC). IARC wishes to make it clear that its motivation is to ensure that scientists are free to openly and critically debate the scientific evidence on whether an agent causes cancer in humans, in the best interests of public health worldwide.
More informations
IARC’s response to questions from a Reuters journalist
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...
The monograph on aspartame, the first monograph in IARC Monographs Volume 134: Aspartame, Methyle...
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the C...